Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential data.
This move was revealed following a government memo dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
An official representative has since stated that the United States was demanding access to genetic material for scientific study and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more negotiations to reach a agreement suitable to both sides so the nation's vital HIV programme can continue.
Wider Context
This development follows a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
According to statements, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our country would supply the basic resources for scientific discovery without any assurance that the resulting innovations would be available to our citizens if a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining structures previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This system is intended to ensure that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued dialogue with our US partners on how subsequent co-operation might be arranged in a manner that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body said it understood the government's concerns, but urged that negotiations should continue given that a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it commented.
The situation highlights the ongoing challenges between accepting vital international aid and safeguarding local interests in an increasingly interconnected world.